$BKYI

BIO KEY INTERNATIONAL INC (BKYI): Submission of Matters to a Vote of Security Holders

BIO KEY INTERNATIONAL INC (BKYI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On September 3, 2026, BIO-key International, Inc. (the “ Company ”) convened its 2026 Annual Meeting of Stockholders (the “ Annual Meeting ”), which was adjourned until Friday, October 2, 2026 at 10:00 a.m., local tim

Original reporting
Published Oct 6, 2026, 8:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$BKYI
Neutral
high confidence
Mentioned
$BKYI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BKYINeutralLow
01

Why it matters

The disclosure is a routine corporate‑governance update with limited immediate price effect, but the pending warrant proposal could become a catalyst.

02

Market read

Low relevance; primarily of interest to existing shareholders and governance‑focused investors.

03

What to watch

The size of the warrant pool (1.24 M shares) could affect future supply if approved.

Relevance 6/10Novelty 4/10Timing: immediate filing, upcoming vote on Oct 30

Background

Bio‑Key International filed a Form 8‑K reporting the outcome of its annual meeting proxy votes and postponing the vote on a warrant‑issuance proposal.

Company-level read

Ticker impact

$BKYINeutralHigh confidence
Context

SEC 8‑K discloses proxy vote results and pending Proposal 4 on the upcoming annual meeting.

Expected impact

likely minimal impact now, modest volatility if Proposal 4 is contentious.

Evidence & confidence

Proxy vote results are routine corporate governance information with limited market effect.

Market effects

none

none

none

Counterpoint

If Proposal 4 involves a large warrant issuance, investors may view it as dilution risk and short the stock.

Key entities

  • Bio‑Key International Inc.

    US‑listed cybersecurity firm (ticker BKYI) reporting proxy results.

Related articles

$CMed

Crude Oil Edges Higher; Citigroup Earnings Top Views

Citigroup (NYSE:C) reported Q3 earnings of $2.85 per share, beating estimates. Bumble (NASDAQ:BMBL) surged 56% after a buyout deal. BIO-Key (NASDAQ:BKYI) rose 139% on a government security contract. Fermi (NASDAQ:FRMI) gained 21% on a credit agreement. Pershing Square (NYSE:PS) fell 11% after a downgrade. Cipher Digital (NASDAQ:CIFR) dropped 14% on a convertible notes offering. Syndax (NASDAQ:SNDX) declined 17% after a trial failure. Oil rose 0.4% to $94.13, while gold and silver fell.

$BKYIMed

BKYI Stock Surges As Gulf Partnership Ignites Trading Frenzy

BIO-key International Inc. (BKYI) stock surged 139.39% on news of a strategic partnership with Dubai-based Al Majlis Group, expanding into the UAE and Saudi Arabia. The company also secured FIDO Alliance Certification for its Passkey:YOU authenticator. BKYI reported $5.9M in revenue, negative profit margins, and a current ratio of 1.3. Traders are watching for execution on new contracts and revenue growth.

$BKYIMed

Cybersecurity Stock BIO-key International (NASDAQ: BKYI) Leads Nasdaq Top Gainers September 29th on News of Expanding Identity Security Across Arabian Gulf

BIO-key International (BKYI) surged 85.71% to $3.12 on September 29th, with a high of $4.66, on news of a partnership with Al Majlis Group to expand its identity security platform in the UAE and Saudi Arabia. The collaboration aims to bring biometric authentication and IAM technology to government and private sector organizations in the region.